Rare hemorrhagic disorder due to an acquired coagulation factor defect Advocacy Hub | UniteRare

At a Glance

Live from database

1 event

Feb 1993

Kogenate: FDA approved

Treatment and prophylaxis of bleeding in patients with hemophilia A (not von Willebrand's disease)

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Kogenate

Bayer Corporation

OpenContact for details

No active clinical trials currently recruiting for Rare hemorrhagic disorder due to an acquired coagulation factor defect.
Search all trials →

No recent news articles indexed yet for Rare hemorrhagic disorder due to an acquired coagulation factor defect.
Search PubMed for Rare hemorrhagic disorder due to an acquired coagulation factor defect →

No specialists currently listed for Rare hemorrhagic disorder due to an acquired coagulation factor defect.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants